PMV Pharmaceuticals

PMVPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$63.465 M

$1.19 +0.85%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$77.7M

Loss-making

Shares outstanding

53,329,392

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#339Pliant TherapeuticsPLRX$65.0M
#340Boundless BioBOLD$64.9M
#341PMV PharmaceuticalsPMVP$63.5M
#342MindWalkHYFT$61.2M
#343Dogwood TherapeuticsDWTX$60.7M

Where these numbers come from

Share counts and financials for PMV Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.